Promus PREMIER™ Everolimus-Eluting Platinum Chromium Stent System ... PR Newswire (press release) 12, 2013 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) has received CE Mark approval for the Promus PREMIER™ Everolimus-Eluting Platinum Chromium Coronary Stent System, the company's next-generation durable polymer drug-eluting ... |
